ERBB2 and breast carcinoma: Our findings that the MDA-MB361 cell line, which is derived from a brain metastasis of breast cancer, can be effectively treated by NIR-PIT using HER2 Affibody–IR700Dye conjugate may extends the therapeutic prospect of this approach for brain metastases.